Results 131 to 140 of about 4,681,502 (208)

Machine learning-based identification of an oxidative phosphorylation signature for prognosis, immune infiltration, and drug sensitivity in ovarian cancer. [PDF]

Front Immunol
Kang L, Yang Z, Ding Y, Wu Y, Ma C, Wang Y, Li C, Li B, Ji G.   +8 more
europepmc   +1 more source

Integrating ex vivo drug sensitivity and genetic mutation analysis improves prediction of chemotherapy response in acute myeloid leukemia. [PDF]

Funct Integr Genomics
Li W, Ji M, Li W, Zhou Y, Jia R, Wen X, Jin S, Hao Y, Dai M, Xu S, Zhou Q, Jiang H, Ji C, Ye J.   +13 more
europepmc   +1 more source

Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivity. [PDF]

Cell Rep Med
Kryeziu K, Klokkerud SK, Totland MZ, Moosavi SH, Reims HM, Bergsland CH, Eilertsen IA, Smeby J, Lassen K, Lundesgaard KK, Syversveen T, Brændengen M, Nesbakken A, Guren TK, Yaqub S, Sveen A, Lothe RA.   +16 more
europepmc   +1 more source

In silico drug sensitivity predicts subgroup-specific therapeutics in medulloblastoma patients. [PDF]

Sci Rep
Jermakowicz AM, Ruiz L, Chu J, Jangde N, Suter RK, Kadan-Lottick NS, Hanson D, Ayad NG.   +7 more
europepmc   +1 more source

Machine learning-based programmed cell death gene signature for prognosis and drug sensitivity in breast cancer. [PDF]

Oncol Lett
Wu N, Fan Z.
europepmc   +1 more source

Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancer. [PDF]

NPJ Precis Oncol
Labrosse KB, Lombardo FC, Bartoszek EM, Sauteur L, Tanner N, Tanna T, Wolf A, Tunkova B, Kasikova L, Fedier A, Lopez MN, Alborelli I, Beisel C, Kurzeder C, Montavon C, Fucíkova J, Heinzelmann-Schwarz V, Jacob F, Coelho R.   +18 more
europepmc   +1 more source

Drug sensitivity testing of patient-derived bone sarcomas identifies selective kinase inhibitors for patients with refractory disease. [PDF]

Clin Transl Oncol
Linder-Stragliotto C, Tsagkozis P, Potdar S, Brodin CA, Brodin BA.   +4 more
europepmc   +1 more source

Personalized treatment of HER2-positive lung adenocarcinoma using Human Organoid Drug Sensitivity Test. [PDF]

Hum Vaccin Immunother
Luan T, Fu S, Liu W, Wang S, Xie X, Lin X, Chenli Z, Wang L, Ma K, Ma H, Mo J, Yu B, Yang Q, Xu Y, Jin H, Chen Q, Yao L, Luan Y, Zhong N, Lv Q, Zhang Y, Zhou C.   +21 more
europepmc   +1 more source